First Commercial Installation of Seracam® at Sellafield By Serac Life Sciences First Commercial Installation of Seracam® at Sellafield Read More »
Seracam® Presentations at Health Physics Society Annual Meeting By Serac Life Sciences Seracam® Presentations at Health Physics Society Annual Meeting Read More »
⁹⁹ᵐTc-Maraciclatide Demonstrates Potential to Differentiate Inflammation from Fibrosis in Interstitial Lung Disease By Serac Life Sciences ⁹⁹ᵐTc-Maraciclatide Demonstrates Potential to Differentiate Inflammation from Fibrosis in Interstitial Lung Disease Read More »
First US Presentation of DETECT Data Demonstrates Semi-Quantitative Assessment of Endometriosis Lesions Using ⁹⁹ᵐTc-Maraciclatid By Serac Life Sciences First US Presentation of DETECT Data Demonstrates Semi-Quantitative Assessment of Endometriosis Lesions Using ⁹⁹ᵐTc-Maraciclatid Read More »
⁹⁹ᵐTc-maraciclatide Abstracts To be Presented at SNMMI 2026 By Serac Life Sciences ⁹⁹ᵐTc-maraciclatide Abstracts To be Presented at SNMMI 2026 Read More »
First Veterinary Imaging Using Seracam® By Serac Life Sciences First Veterinary Imaging Using Seracam® Read More »
Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women’s Health Highlights ⁹⁹ᵐTc-maraciclatide as a Promising Diagnostic and Monitoring Tool By Serac Life Sciences Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women’s Health Highlights ⁹⁹ᵐTc-maraciclatide as a Promising Diagnostic and Monitoring Tool Read More »
Endometriosis Imaging with 99mTc-maraciclatide Presented at European Endometriosis Congress 2026 By Serac Life Sciences Endometriosis Imaging with 99mTc-maraciclatide Presented at European Endometriosis Congress 2026 Read More »
DETECT Abstracts Selected for Oral Presentation at European Endometriosis Congress 2026 By Serac Life Sciences DETECT Abstracts Selected for Oral Presentation at European Endometriosis Congress 2026 Read More »
⁹⁹ᵐTc-maraciclatide Granted FDA Fast Track Designation for the Visualization of Inflammation in Interstitial Lung Disease By Serac Life Sciences ⁹⁹ᵐTc-maraciclatide Granted FDA Fast Track Designation for the Visualization of Inflammation in Interstitial Lung Disease Read More »
